Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. McCafferty (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom), B. Walker (Belfast (Belfast), United Kingdom). Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum. 2349

Member's Comments

No comment yet.

Related content which might interest you: Development of a novel immunoassay for the measurement of active plasmin in patients with IPF Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 The development of a novel immunoassay for the quantification of active tryptase Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 Development of the first protease multiplex immunoassay for active neutrophilic serine protease biomarkers Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD Source: Eur Respir J, 55 (5) 1902412; 10.1183/13993003.02412-2019 Year: 2020 Investigating optimal sputum processing methods for active neutrophil elastase quantification Source: International Congress 2017 – Techniques in biomarker selection Year: 2017 Comparison of enzyme immunoassays for the measurement of soy aeroallergens Source: Eur Respir J 2005; 26: Suppl. 49, 36s Year: 2005 An innovative high sensitivity tool for active neutrophil elastase quantification Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Usefulness of whole blood interferon-γ assay and interferon-γ enzyme-linked immunospot assay for the diagnosis of active tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 The adaptation of a point of care test for the quantitative determination of active neutrophil elastase in sputum Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 A novel point of care test for sputum sample stratification prior to the quantitative measurement of active neutrophil elastase Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Validation of TNF-α determinations by homogeneous time-resolved fluorescence A comparison between HTRF® and ELISA in human whole blood assays Source: Eur Respir J 2003; 22: Suppl. 45, 228s Year: 2003 Evaluation of novel sputum processing methods and sensitive detection techniques in allergic asthmatics Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function? Year: 2009 New enzyme linked immunosorbent assay using recombinant antigens from Saccharopolyspora rectivirgula for farmer‘s lung disease serodiagnosis Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012 Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology Year: 2010 Clinical evaluation of anti-glycopeptidelipid core immunoglobulin A antibody assay for serodiagnosis of pulmonary Mycobacterium avium-intracellulare complex (MAC) disease Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005 Identification of bacterial pulmonary infection by a PCR based rapid molecular diagnostic assay in bronchoalveolar lavage Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells Source: Eur Respir J, 59 (1) 2100285; 10.1183/13993003.00285-2021 Year: 2022 A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016